After-Hours Stock Movers 12/06: (ACAD) (MDB) (DWAC) Higher; (HQY) (OWL) (SI) Lower (more...)
- Wall Street rallies, capping frenetic week with best day of the year
- Apple (AAPL) Stock Soars on Another Robust Quarter Fueled by Monster iPhone and Services Numbers, Analysts Raise PTs
- BofA Raises Inflation Forecasts for 2022, Expects Fed to Hike 7 Times in 2022
- Netflix (NFLX) CEO Hastings Buys ~$20 Million in Stock Following Sell-Off, Ackman's Big Bet
- Oil hits 7-year peak on political risks, supply crunch
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
After-Hous Stock Movers
HealthEquity (NASDAQ: HQY) 26% LOWER; reported Q3 EPS of $0.35, in-line with the analyst estimate of $0.35. Revenue for the quarter came in at $180 million versus the consensus estimate of $185.05 million. HealthEquity sees FY2022 EPS of $1.30-$1.35, versus the consensus of $1.48. HealthEquity sees FY2022 revenue of $750-755 million, versus the consensus of $762.3 million.
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) 23.8% HIGHER; announced positive top-line results from the pivotal, Phase 3 Lavender study evaluating the efficacy and safety of trofinetide in 187 girls and young women aged 5-20 years with Rett syndrome. The 12-week placebo-controlled study demonstrated a statistically significant improvement over placebo for both co-primary endpoints. On the Rett Syndrome Behaviour Questionnaire (RSBQ), change from baseline to week 12 was -5.1 vs. -1.7 (p=0.0175; effect size=0.37). The Clinical Global ImpressionImprovement (CGI-I) score at week 12 was 3.5 vs. 3.8 (p=0.0030; effect size=0.47). The RSBQ is a caregiver assessment of the core symptoms of Rett syndrome and the CGI-I is a global physician assessment of worsening or improving of Rett syndrome.
MongoDB (NASDAQ: MDB) 15.5% HIGHER; reported Q3 EPS of ($0.11), $0.26 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $226.9 million versus the consensus estimate of $205.14 million. MongoDB sees Q4 2022 EPS of ($0.24)-($0.21), versus the consensus of ($0.34). MongoDB sees Q4 2022 revenue of $239-242 million, versus the consensus of $227.7 million.
Blue Owl Capital Inc. (NYSE: OWL) 10.8% LOWER; announced today that NBSH Blue Investments II, LLC, intends to offer in an underwritten public offering 26,717,377 shares of the Company's Class A common stock.
Taysha Gene Therapies, Inc. (Nasdaq: TSHA) 10.7% HIGHER; announced a late-breaking abstract and poster presentation by Dr. Rachel Bailey, Assistant Professor at UT Southwestern Medical Center on positive preclinical data for TSHA-105, an AAV9-based gene therapy in development for SLC13A5-related epilepsy at the American Epilepsy Society Annual Meeting on December 6th 2021.
Silvergate Capital Corporation (NYSE: SI) 7% LOWER; announced today the launch of an underwritten public offering of $400 million of shares of Class A common stock. The Company also expects to grant the underwriters a 30-day option to purchase up to an additional $60 million of shares of Class A common stock.
Shineco, Inc. (NASDAQ: SISI) 7% LOWER; entered into a securities purchase agreement (the “Agreement”) for the sale of Gross Proceeds US$2.0 million of its registered common stock at a price of $6.8546 per share with GHS Investments, LLC.
Digital World Acquisition Corp. (NASDAQ: DWAC) 5.6% HIGHER; Trump Media & Technology Group (TMTG) today announced that Congressman Devin G. Nunes has been selected to join the Company as Chief Executive Officer. Mr. Nunes is currently a sitting U.S. House Representative, representing Californias 22nd congressional district, and formerly the Chair of the House Intelligence Committee. Mr. Nunes will be leaving the U.S. House of Representatives and will begin his new role as Chief Executive Officer of TMTG in January 2022.
Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) 3.2% LOWER; today announced that it has commenced an underwritten public offering to sell 7,700,000 shares of common stock
Sumo Logic Inc. (NASDAQ: SUMO) 2% HIGHER; reported Q3 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $62 million versus the consensus estimate of $60.86 million. Sumo Logic Inc. sees FY2022 EPS of ($0.51)-($0.50), versus the consensus of ($0.51). Sumo Logic Inc. sees FY2022 revenue of $238-239.8 million, versus the consensus of $238 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-Hours Stock Movers 01/27: (CLFD) (TEAM) (AAPL) Higher; (WDC) (MDLZ) (SI) Lower (more...)
- After-Hours Stock Movers 01/20: (LLNW) (RGLS) Higher; (NFLX) (ISRG) (PPG) Lower (more...)
- Sirius XM (SIRI) February weekly 6 straddle priced for a move of +/- 10% into quarter results
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesAfter-Hours Movers
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!